Beyond uncovering tumor suppressive functions of RNF180 and its mechanism of regulation on WISP1, our findings have presented a novel therapeutic strategy to restore RNF180/WISP1 pathway for CRC treatment. This evidence concerns the gene CCN4 and colorectal carcinoma.